Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma

Clinical trial NCT03390595 · COMPLETED

Trial details

NCT number: NCT03390595
Sponsor: Associació per a la Recerca Oncologica, Spain
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Urothelial Cancer

Start date: 2018-05-17
Primary completion: 2022-08-31
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.